Prevalence of co-existent neoplasia in clinically diagnosed pterygia in a UK population

Eye (Lond). 2023 Dec;37(18):3757-3761. doi: 10.1038/s41433-023-02594-w. Epub 2023 May 26.

Abstract

Introduction: Ocular surface squamous neoplasia (OSSN) and pterygia share risk factors and co-exist in only a minority of cases. Reported rates of OSSN in specimens sent as pterygium for histopathological analysis vary between 0% and nearly 10%, with the highest rates reported in countries with high levels of ultraviolet light exposure. As there is a paucity of data in European populations, the aim of this study was to report the prevalence of co-existent OSSN or other neoplastic disease in clinically suspected pterygium specimens sent to a specialist ophthalmic pathology service in London, United Kingdom.

Methods: We performed a retrospective review of sequential histopathology records of patients with excised tissue submitted as suspected "pterygium" between 1997 and 2021.

Results: In total, 2061 specimens of pterygia were received during the 24-year period, with a prevalence of neoplasia in those specimens of 0.6% (n = 12). On detailed review of the medical records of these patients, half (n = 6) had the pre-operative clinical suspicion of possible OSSN. Of those cases without clinical suspicion pre-operatively, one was diagnosed with invasive squamous cell carcinoma of the conjunctiva.

Conclusion: In this study, rates of unexpected diagnoses are reassuringly low. These results may challenge accepted dogma, and influence future guidance for the indications for submitting non-suspicious pterygia for histopathological analysis.

MeSH terms

  • Conjunctiva / pathology
  • Conjunctival Neoplasms* / pathology
  • Eye Neoplasms* / diagnosis
  • Eye Neoplasms* / epidemiology
  • Eye Neoplasms* / pathology
  • Humans
  • Prevalence
  • Pterygium* / diagnosis
  • Pterygium* / epidemiology
  • Pterygium* / pathology

Supplementary concepts

  • Pterygium Of Conjunctiva And Cornea